DSG1
Desmoglein-1
Also known as: CDHF4, DSG, DSG1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02413
- Gene
- DSG1
- Ensembl
- ENSG00000134760
- Chromosome
- 18
- Canonical length
- 1049 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a member of the desmoglein protein subfamily. Desmogleins, along with desmocollins, are cadherin-like transmembrane glycoproteins that are major components of the desmosome. Desmosomes are cell-cell junctions that help resist shearing forces and are found in high concentrations in cells subject to mechanical stress. This gene is found in a cluster with other desmoglein family members on chromosome 18. The encoded protein has been identified as a target of auto-antibodies in the autoimmune skin blistering disease pemphigus foliaceus. Disruption of this gene has also been associated with the skin diseases palmoplantar keratoderma and erythroderma. [provided by RefSeq, Feb 2015]
Canonical amino-acid sequenceUniProt
1049 residues, UniProt reviewed canonical sequence.
>Q02413|DSG1
1 MDWSFFRVVA MLFIFLVVVE VNSEFRIQVR DYNTKNGTIK WHSIRRQKRE WIKFAAACRE
61 GEDNSKRNPI AKIHSDCAAN QQVTYRISGV GIDQPPYGIF VINQKTGEIN ITSIVDREVT
121 PFFIIYCRAL NSMGQDLERP LELRVRVLDI NDNPPVFSMA TFAGQIEENS NANTLVMILN
181 ATDADEPNNL NSKIAFKIIR QEPSDSPMFI INRNTGEIRT MNNFLDREQY GQYALAVRGS
241 DRDGGADGMS AECECNIKIL DVNDNIPYME QSSYTIEIQE NTLNSNLLEI RVIDLDEEFS
301 ANWMAVIFFI SGNEGNWFEI EMNERTNVGI LKVVKPLDYE AMQSLQLSIG VRNKAEFHHS
361 IMSQYKLKAS AISVTVLNVI EGPVFRPGSK TYVVTGNMGS NDKVGDFVAT DLDTGRPSTT
421 VRYVMGNNPA DLLAVDSRTG KLTLKNKVTK EQYNMLGGKY QGTILSIDDN LQRTCTGTIN
481 INIQSFGNDD RTNTEPNTKI TTNTGRQEST SSTNYDTSTT STDSSQVYSS EPGNGAKDLL
541 SDNVHFGPAG IGLLIMGFLV LGLVPFLMIC CDCGGAPRSA AGFEPVPECS DGAIHSWAVE
601 GPQPEPRDIT TVIPQIPPDN ANIIECIDNS GVYTNEYGGR EMQDLGGGER MTGFELTEGV
661 KTSGMPEICQ EYSGTLRRNS MRECREGGLN MNFMESYFCQ KAYAYADEDE GRPSNDCLLI
721 YDIEGVGSPA GSVGCCSFIG EDLDDSFLDT LGPKFKKLAD ISLGKESYPD LDPSWPPQST
781 EPVCLPQETE PVVSGHPPIS PHFGTTTVIS ESTYPSGPGV LHPKPILDPL GYGNVTVTES
841 YTTSDTLKPS VHVHDNRPAS NVVVTERVVG PISGADLHGM LEMPDLRDGS NVIVTERVIA
901 PSSSLPTSLT IHHPRESSNV VVTERVIQPT SGMIGSLSMH PELANAHNVI VTERVVSGAG
961 VTGISGTTGI SGGIGSSGLV GTSMGAGSGA LSGAGISGGG IGLSSLGGTA SIGHMRSSSD
1021 HHFNQTIGSA SPSTARSRIT KYSTVQYSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DSG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 533 nTPM
Expression across tissuesHPA
Tissue
- skin: 533 nTPM
- vagina: 25 nTPM
- breast: 23 nTPM
- cervix: 20 nTPM
- esophagus: 17 nTPM
- salivary gland: 10 nTPM
Single-cell type
- suprabasal keratinocytes: 1,054 nCPM
- ocular epithelial cells: 913 nCPM
- basal keratinocytes: 335 nCPM
- esophageal suprabasal cells: 162 nCPM
- esophageal apical cells: 96 nCPM
- esophageal basal cells: 25 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- amygdala: 0.1 nTPM
- basal ganglia: 0.1 nTPM
- hippocampal formation: 0.1 nTPM
- hypothalamus: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DSG1.
Disease | AllUniProt
Conditions DSG1 is implicated in, by any mechanism.
- Palmoplantar keratoderma 1, striate, focal, or diffuse (PPKS1) MIM:148700
- Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE (EPKHE) MIM:615508
Disease | GeneticClinVar
45 pathogenic / likely-pathogenic of 964 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Palmoplantar keratoderma i, striate, focal, or diffuse
- Severe dermatitis-multiple allergies-metabolic wasting syndrome
- Hereditary palmoplantar keratoderma
- DSG1-related disorder
- Epidermal disease
Disease | ImmuneIEDB
Conditions an epitope on DSG1 was assayed in.
- pemphigus B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against DSG1 are reported. Each links to that disease's full target list.
- Pemphigus 273
- Blister 12
- Skin Diseases, Vesiculobullous 10
- Pemphigoid, Bullous 6
- Psoriasis 4
- Arthritis, Rheumatoid 3
Showing 6 of 11 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for DSG1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
322 publications
- Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.
1997 · J Immunol · RCR 11.3 · 372 citations - Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
1999 · J Clin Invest · RCR 9.9 · 349 citations - The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
2001 · Br J Dermatol · RCR 6.8 · 190 citations - Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles.
1997 · J Invest Dermatol · RCR 6 · 184 citations - Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus.
1995 · J Invest Dermatol · RCR 5.8 · 197 citations
Show 20 more of 322 total
- Modern diagnosis of autoimmune blistering skin diseases.
2010 · Autoimmun Rev · RCR 4.7 · 134 citations - Autoantibody-Specific Signalling in Pemphigus.
2021 · Front Med (Lausanne) · RCR 4.7 · 60 citations - Paraneoplastic pemphigus in children and adolescents.
2002 · Br J Dermatol · RCR 4.4 · 120 citations - ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
2009 · Arch Dermatol · RCR 4.2 · 120 citations - Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review.
2018 · Int Immunopharmacol · RCR 4.1 · 70 citations - Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
2010 · Exp Dermatol · RCR 3.8 · 102 citations - Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
2020 · JAMA Dermatol · RCR 3.7 · 55 citations - Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1.
1998 · J Invest Dermatol · RCR 3.6 · 131 citations - Paraneoplastic pemphigus in association with Castleman's disease.
2003 · Br J Dermatol · RCR 3.6 · 106 citations - Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
2000 · J Clin Invest · RCR 3.4 · 130 citations - Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management.
2002 · Crit Rev Oral Biol Med · RCR 3.4 · 86 citations - Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes.
1991 · J Clin Endocrinol Metab · RCR 3.4 · 142 citations - Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
2005 · Br J Dermatol · RCR 3.3 · 115 citations - The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem).
2003 · J Exp Med · RCR 3.3 · 147 citations - Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction.
2005 · J Clin Invest · RCR 3.3 · 133 citations - Japanese guidelines for the management of pemphigus.
2014 · J Dermatol · RCR 3.3 · 68 citations - Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3.
2000 · Clin Exp Dermatol · RCR 3.2 · 79 citations - The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research.
2000 · N Engl J Med · RCR 3.1 · 109 citations - Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins.
2001 · J Immunol · RCR 3.1 · 129 citations - Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus pathogenesis.
2024 · J Autoimmun · RCR 3 · 10 citations
Reference: B cellIEDB
5 publications
- Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence.
2009 · J Invest Dermatol · RCR 1.3 · 48 citations - Pathogenic IgG4 autoantibodies from endemic pemphigus foliaceus recognize a desmoglein-1 conformational epitope.
2018 · J Autoimmun · RCR 1 · 19 citations - Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous.
2006 · J Transl Med · RCR 0.8 · 26 citations - Epitope analysis of antidesmoglein 1 autoantibodies from patients with pemphigus foliaceus across different activity stages.
2016 · Br J Dermatol · RCR 0.3 · 7 citations - The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies.
2013 · J Pept Sci · RCR 0.1 · 3 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.93
- gnomAD missense Z
- -0.34
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
- cell-cell adhesion
- cell-cell junction assembly
- homophilic cell adhesion via plasma membrane adhesion molecules
- maternal process involved in female pregnancy
- protein stabilization
- response to progesterone
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DSG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DSG1 as an antibody target. Whether an autoantibody or antibody against DSG1 could matter depends on whether native DSG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DSG1 is annotated at the cell surface, where native DSG1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- The encoded protein has been identified as a target of auto-antibodies in the autoimmune skin blistering disease pemphigus foliaceus.
Loading the interactive Seroatlas protein explorer...